Acadia Pharmaceuticals buy StockNews.com
Start price
11.01.26
/
50%
€23.07
Target price
11.01.27
-
Performance (%)
-16.58%
Price
02.04.26
€19.25
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.58%. This prediction currently runs until 11.01.27. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 1.077% | 1.077% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by StockNews_com for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by StockNews_com for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.60
14.09.24
14.09.24
-
14.09.25
14.09.25
36.96%
15.09.25
15.09.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.09
03.08.24
03.08.24
-
03.08.25
03.08.25
18.53%
04.08.25
04.08.25

